相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells
Defeng Xu et al.
CANCER LETTERS (2012)
Androgen deprivation causes truncation of the C-terminal region of androgen receptor in human prostate cancer LNCaP cells
Naoki Harada et al.
CANCER SCIENCE (2012)
The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells
Defeng Xu et al.
PROSTATE (2012)
Inhibiting aberrant Stat3 function with molecular therapeutics: a progress report
Sina Haftchenary et al.
ANTI-CANCER DRUGS (2011)
Estrogen receptor alpha pathway is involved in leptin-induced ovarian cancer cell growth
Jung-Hye Choi et al.
CARCINOGENESIS (2011)
STAT3α Is Oncogenic for Endometrial Carcinoma Cells and Mediates the Oncogenic Effects of Autocrine Human Growth Hormone
Jian-Zhong Tang et al.
ENDOCRINOLOGY (2010)
Hormone prevention strategies for breast, endometrial and ovarian cancers
Laurel W. Rice
GYNECOLOGIC ONCOLOGY (2010)
Expression of estrogen receptor alpha increases leptin-induced STAT3 activity in breast cancer cells
Nadine A. Binai et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Cyclin D1 Enhances the Response to Estrogen and Progesterone by Regulating Progesterone Receptor Expression
Chuanwei Yang et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Estrogen Receptor Regulates E2F1 Expression to Mediate Tamoxifen Resistance
Maggie C. Louie et al.
MOLECULAR CANCER RESEARCH (2010)
Mechanisms of estrogen receptor-α upregulation in breast cancers
Yasuo Miyoshi et al.
MEDICAL MOLECULAR MORPHOLOGY (2010)
Ovarian cancer ascites protects from TRAIL-induced cell death through αvβ5 integrin-mediated focal adhesion kinase and Akt activation
D. Lane et al.
ONCOGENE (2010)
ER-α36, a Novel Variant of ER-α, Mediates Estrogen-Stimulated Proliferation of Endometrial Carcinoma Cells via the PKCδ/ERK Pathway
Jing-Shan Tong et al.
PLOS ONE (2010)
Nuclear Phospho-Akt Increase Predicts Synergy of PI3K Inhibition and Doxorubicin in Breast and Ovarian Cancer
Jeffrey J. Wallin et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Inhibition of Snake Venoms and Phospholipases A2 by Extracts from Native and Genetically Modified Eclipta alba: Isolation of Active Coumestans
Luciana C. Diogo et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2009)
CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells
Ming Chen et al.
CARCINOGENESIS (2009)
Herbal Extract of Wedelia chinensis Attenuates Androgen Receptor Activity and Orthotopic Growth of Prostate Cancer in Nude Mice
Chin-Hsien Tsai et al.
CLINICAL CANCER RESEARCH (2009)
Differential induction of LRP16 by liganded and unliganded estrogen receptor α in SKOV3 ovarian carcinoma cells
Liyuan Tian et al.
JOURNAL OF ENDOCRINOLOGY (2009)
Integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer
Katherine Stemke-Hale et al.
CANCER RESEARCH (2008)
Estrogen regulates snail and slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor α
Se-Hyung Park et al.
MOLECULAR ENDOCRINOLOGY (2008)
Inhibition of NFκB reduces cellular viability in GH3 pituitary adenoma cells
John R. Vender et al.
NEUROSURGERY (2008)
ERAP75 functions as a coactivator to enhance estrogen receptor α transactivation in prostate stromal cells
Ming Chen et al.
PROSTATE (2008)
Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells
Feng-Min Lin et al.
CARCINOGENESIS (2007)
Differential retention of α-vitamin E is correlated with its transporter gene expression and growth inhibition efficacy in prostate cancer cells
Jing Ni et al.
PROSTATE (2007)
RB and cell cycle progression
C. Giacinti et al.
ONCOGENE (2006)
The Myc oncoprotein as a therapeutic target for human cancer
Marina Vita et al.
SEMINARS IN CANCER BIOLOGY (2006)
The Akt pathway in human breast cancer: a tissue-array-based analysis
S Bose et al.
MODERN PATHOLOGY (2006)
The Src kinase pathway promotes tamoxifen agonist action in ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor α promoter interaction and elevated steroid receptor coactivator 1 activity
YM Shah et al.
MOLECULAR ENDOCRINOLOGY (2005)
Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium
S Bircan et al.
PATHOLOGY & ONCOLOGY RESEARCH (2005)
Medicinal plants with inhibitory properties against snake venoms
AM Soares et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK Complex
M Kobori et al.
CELL DEATH AND DIFFERENTIATION (2004)
Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells
ZO Wang et al.
ONCOGENE (2002)
Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells
SY Yeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells
S Misiti et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Estrogen receptor α gene polymorphisms and endometrial cancer risk
E Weiderpass et al.
CARCINOGENESIS (2000)
Selective estrogen receptor modulators: Structure, function, and clinical use
CK Osborne et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
